[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States HPV Therapeutic Vaccines Market Report 2017

August 2017 | 104 pages | ID: UD705A83FC8EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States HPV Therapeutic Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of HPV Therapeutic Vaccines in these regions, from 2012 to 2022 (forecast).
United States HPV Therapeutic Vaccines market competition by top manufacturers/players, with HPV Therapeutic Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Merck & Co., Inc.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Coridon
  • Gentical
  • Advaxis
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Bivalent HPV Vaccine
  • Quadrivalent HPV Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of HPV Therapeutic Vaccines for each application, including
  • Hospitals
  • Specialty Clinics
If you have any special requirements, please let us know and we will offer you the report as you want.
United States HPV Therapeutic Vaccines Market Report 2017

1 HPV THERAPEUTIC VACCINES OVERVIEW

1.1 Product Overview and Scope of HPV Therapeutic Vaccines
1.2 Classification of HPV Therapeutic Vaccines by Product Category
  1.2.1 United States HPV Therapeutic Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States HPV Therapeutic Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Bivalent HPV Vaccine
  1.2.4 Quadrivalent HPV Vaccine
1.3 United States HPV Therapeutic Vaccines Market by Application/End Users
  1.3.1 United States HPV Therapeutic Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Specialty Clinics
1.4 United States HPV Therapeutic Vaccines Market by Region
  1.4.1 United States HPV Therapeutic Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West HPV Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest HPV Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic HPV Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.5 New England HPV Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.6 The South HPV Therapeutic Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest HPV Therapeutic Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of HPV Therapeutic Vaccines (2012-2022)
  1.5.1 United States HPV Therapeutic Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States HPV Therapeutic Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES HPV THERAPEUTIC VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States HPV Therapeutic Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States HPV Therapeutic Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States HPV Therapeutic Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States HPV Therapeutic Vaccines Market Competitive Situation and Trends
  2.4.1 United States HPV Therapeutic Vaccines Market Concentration Rate
  2.4.2 United States HPV Therapeutic Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers HPV Therapeutic Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HPV THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States HPV Therapeutic Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States HPV Therapeutic Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States HPV Therapeutic Vaccines Price by Region (2012-2017)

4 UNITED STATES HPV THERAPEUTIC VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States HPV Therapeutic Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States HPV Therapeutic Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States HPV Therapeutic Vaccines Price by Type (2012-2017)
4.4 United States HPV Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HPV THERAPEUTIC VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States HPV Therapeutic Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States HPV Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HPV THERAPEUTIC VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 HPV Therapeutic Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. HPV Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline Pharmaceuticals Ltd.
  6.2.2 HPV Therapeutic Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Pharmaceuticals Ltd. HPV Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Coridon
  6.3.2 HPV Therapeutic Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Coridon HPV Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Gentical
  6.4.2 HPV Therapeutic Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Gentical HPV Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Advaxis
  6.5.2 HPV Therapeutic Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Advaxis HPV Therapeutic Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 HPV THERAPEUTIC VACCINES MANUFACTURING COST ANALYSIS

7.1 HPV Therapeutic Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of HPV Therapeutic Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 HPV Therapeutic Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of HPV Therapeutic Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HPV THERAPEUTIC VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States HPV Therapeutic Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States HPV Therapeutic Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States HPV Therapeutic Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States HPV Therapeutic Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of HPV Therapeutic Vaccines
Figure United States HPV Therapeutic Vaccines Market Size (MT) by Type (2012-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Bivalent HPV Vaccine Product Picture
Figure Quadrivalent HPV Vaccine Product Picture
Figure United States HPV Therapeutic Vaccines Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of HPV Therapeutic Vaccines by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Specialty Clinics Examples
Table Key Downstream Customer in Specialty Clinics
Figure United States HPV Therapeutic Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States HPV Therapeutic Vaccines Sales (MT) and Growth Rate (2012-2022)
Figure United States HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States HPV Therapeutic Vaccines Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States HPV Therapeutic Vaccines Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States HPV Therapeutic Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States HPV Therapeutic Vaccines Sales Share by Players/Suppliers
Figure 2017 United States HPV Therapeutic Vaccines Sales Share by Players/Suppliers
Figure United States HPV Therapeutic Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States HPV Therapeutic Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States HPV Therapeutic Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States HPV Therapeutic Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States HPV Therapeutic Vaccines Revenue Share by Players/Suppliers
Table United States Market HPV Therapeutic Vaccines Average Price (K USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market HPV Therapeutic Vaccines Average Price (K USD/Kg) of Key Players/Suppliers in 2016
Figure United States HPV Therapeutic Vaccines Market Share of Top 3 Players/Suppliers
Figure United States HPV Therapeutic Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers HPV Therapeutic Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers HPV Therapeutic Vaccines Product Category
Table United States HPV Therapeutic Vaccines Sales (MT) by Region (2012-2017)
Table United States HPV Therapeutic Vaccines Sales Share by Region (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Share by Region (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Market Share by Region in 2016
Table United States HPV Therapeutic Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States HPV Therapeutic Vaccines Revenue Share by Region (2012-2017)
Figure United States HPV Therapeutic Vaccines Revenue Market Share by Region (2012-2017)
Figure United States HPV Therapeutic Vaccines Revenue Market Share by Region in 2016
Table United States HPV Therapeutic Vaccines Price (K USD/Kg) by Region (2012-2017)
Table United States HPV Therapeutic Vaccines Sales (MT) by Type (2012-2017)
Table United States HPV Therapeutic Vaccines Sales Share by Type (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Share by Type (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Market Share by Type in 2016
Table United States HPV Therapeutic Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States HPV Therapeutic Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of HPV Therapeutic Vaccines by Type (2012-2017)
Figure Revenue Market Share of HPV Therapeutic Vaccines by Type in 2016
Table United States HPV Therapeutic Vaccines Price (K USD/Kg) by Types (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Growth Rate by Type (2012-2017)
Table United States HPV Therapeutic Vaccines Sales (MT) by Application (2012-2017)
Table United States HPV Therapeutic Vaccines Sales Market Share by Application (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Market Share by Application (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Market Share by Application in 2016
Table United States HPV Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States HPV Therapeutic Vaccines Sales Growth Rate by Application (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. HPV Therapeutic Vaccines Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. HPV Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. HPV Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. HPV Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Pharmaceuticals Ltd. Basic Information List
Table GlaxoSmithKline Pharmaceuticals Ltd. HPV Therapeutic Vaccines Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Pharmaceuticals Ltd. HPV Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Pharmaceuticals Ltd. HPV Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Pharmaceuticals Ltd. HPV Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Coridon Basic Information List
Table Coridon HPV Therapeutic Vaccines Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Coridon HPV Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Coridon HPV Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Coridon HPV Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Gentical Basic Information List
Table Gentical HPV Therapeutic Vaccines Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Gentical HPV Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Gentical HPV Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Gentical HPV Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Advaxis Basic Information List
Table Advaxis HPV Therapeutic Vaccines Sales (MT), Revenue (Million USD), Price (K USD/Kg) and Gross Margin (2012-2017)
Figure Advaxis HPV Therapeutic Vaccines Sales Growth Rate (2012-2017)
Figure Advaxis HPV Therapeutic Vaccines Sales Market Share in United States (2012-2017)
Figure Advaxis HPV Therapeutic Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of HPV Therapeutic Vaccines
Figure Manufacturing Process Analysis of HPV Therapeutic Vaccines
Figure HPV Therapeutic Vaccines Industrial Chain Analysis
Table Raw Materials Sources of HPV Therapeutic Vaccines Major Players/Suppliers in 2016
Table Major Buyers of HPV Therapeutic Vaccines
Table Distributors/Traders List
Figure United States HPV Therapeutic Vaccines Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States HPV Therapeutic Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States HPV Therapeutic Vaccines Price (K USD/Kg) Trend Forecast (2017-2022)
Table United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Type in 2022
Table United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Application in 2022
Table United States HPV Therapeutic Vaccines Sales Volume (MT) Forecast by Region (2017-2022)
Table United States HPV Therapeutic Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States HPV Therapeutic Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories